These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 8609716

  • 21. Differentiating therapy with all-trans retinoic acid in acute myeloid leukemia.
    Tallman MS.
    Leukemia; 1996 Apr; 10 Suppl 1():S12-5. PubMed ID: 8618462
    [Abstract] [Full Text] [Related]

  • 22. All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignancies.
    Tallman MS.
    Semin Hematol; 1994 Oct; 31(4 Suppl 5):38-48. PubMed ID: 7831584
    [Abstract] [Full Text] [Related]

  • 23. The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia.
    Niitsu N, Higashihara M, Honma Y.
    Exp Hematol; 2002 Nov; 30(11):1273-82. PubMed ID: 12423680
    [Abstract] [Full Text] [Related]

  • 24. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
    Billottet C, Banerjee L, Vanhaesebroeck B, Khwaja A.
    Cancer Res; 2009 Feb 01; 69(3):1027-36. PubMed ID: 19176369
    [Abstract] [Full Text] [Related]

  • 25. [Mechanism of action of retinoids in a new therapeutic approach to acute promyelocytic leukemia].
    Cornic M, Guidez F, Delva L, Agadir A, Degos L, Chomienne C.
    Bull Cancer; 1992 Feb 01; 79(7):697-704. PubMed ID: 1334741
    [Abstract] [Full Text] [Related]

  • 26. Apoptosis induction by (+)alpha-tocopheryl succinate in the absence or presence of all-trans retinoic acid and arsenic trioxide in NB4, NB4-R2 and primary APL cells.
    Freitas RA, Silva dos Santos GA, Gimenes Teixeira HL, Scheucher PS, Lucena-Araujo AR, Lima AS, Abreu e Lima RS, Garcia AB, Jordão AA, Falcão RP, Vannucchi H, Rego EM.
    Leuk Res; 2009 Jul 01; 33(7):958-63. PubMed ID: 19013639
    [Abstract] [Full Text] [Related]

  • 27. [In vitro study on realgar induced apoptosis of all-trans acid resistant acute promeylocytic leukemia cell line (MR2)].
    Chen SY, Liu SX, Li XM.
    Zhongguo Zhong Yao Za Zhi; 2002 Mar 01; 27(3):211-5. PubMed ID: 12774405
    [Abstract] [Full Text] [Related]

  • 28. Effect of cytokines on the proliferation and differentiation of acute promyelocytic leukemia cells: possible relationship to the development of "retinoic acid syndrome".
    Nakamaki T, Hino K, Yokoyama A, Hisatake J, Tomoyasu S, Honma Y, Hozumi M, Tsuruoka N.
    Anticancer Res; 1994 Mar 01; 14(3A):817-23. PubMed ID: 7521152
    [Abstract] [Full Text] [Related]

  • 29. Differential uptake of all-trans retinoic acid by acute promyelocytic leukemic cells: evidence for its role in retinoic acid efficacy.
    Agadir A, Cornic M, Lefebvre P, Gourmel B, Balitrand N, Degos L, Chomienne C.
    Leukemia; 1995 Jan 01; 9(1):139-45. PubMed ID: 7845008
    [Abstract] [Full Text] [Related]

  • 30. All-trans retinoic acid pharmacokinetics and bioavailability in acute promyelocytic leukemia: intracellular concentrations and biologic response relationship.
    Agadir A, Cornic M, Lefebvre P, Gourmel B, Jérôme M, Degos L, Fenaux P, Chomienne C.
    J Clin Oncol; 1995 Oct 01; 13(10):2517-23. PubMed ID: 7595702
    [Abstract] [Full Text] [Related]

  • 31. Expression and ATRA-driven modulation of adhesion molecules in acute promyelocytic leukemia.
    Di Noto R, Schiavone EM, Ferrara F, Manzo C, Lo Pardo C, Del Vecchio L.
    Leukemia; 1994 Nov 01; 8(11):1900-5. PubMed ID: 7967734
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Increased sensitivity to a vitamin D3 analog in HL-60 myeloid leukemic cells resistant to all-trans retinoic acid.
    Doré BT, Uskokovic MR, Momparler RL.
    Leukemia; 1994 Dec 01; 8(12):2179-82. PubMed ID: 7528858
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. RACK1 deficiency synergizes with all-trans retinoic acid to induce apoptosis in human acute promyelocytic leukemia cells.
    Wu H, Liu J, Huang X, Pian L, Cheng Q, Wang Q, Zhao M, Lin Z, Shen B, Zhang J, Li S, Wang J.
    Mol Cell Biochem; 2019 Jan 01; 451(1-2):155-163. PubMed ID: 30019299
    [Abstract] [Full Text] [Related]

  • 38. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells.
    Dubois C, Schlageter MH, de Gentile A, Guidez F, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y.
    Blood; 1994 Jun 01; 83(11):3264-70. PubMed ID: 8193361
    [Abstract] [Full Text] [Related]

  • 39. Real-time PCR analysis of the apoptosis related genes in ATRA treated APL t(15;17) patients.
    Savli H, Sirma S, Nagy B, Aktan M, Dincol G, Ozbek U.
    Exp Mol Med; 2003 Oct 31; 35(5):454-9. PubMed ID: 14646600
    [Abstract] [Full Text] [Related]

  • 40. In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
    Dombret H, Scrobohaci ML, Daniel MT, Micléa JM, Castaigne S, Chomienne C, Fenaux P, Degos L.
    Leukemia; 1995 Jan 31; 9(1):19-24. PubMed ID: 7531260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.